Crescent Capital BDC (CCAP) CEO buys 5,000 shares in open market

Rhea-AI Filing Summary

Crescent Capital BDC, Inc. Chief Executive Officer Jason Breaux bought additional company stock in an open-market transaction. On May 20, 2026, he purchased 5,000 shares of Common Stock at $11.19 per share. Following this purchase, his direct holdings increased to 52,636 shares of Crescent Capital BDC, Inc. Common Stock.

Insider Trade Summary

Net Buyer: 5,000 shares ($55,950)

Net Buy 1 txn

Insider Breaux Jason

Role Chief Executive Officer

Bought 5,000 shs ($56K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	5,000	$11.19	$56K

Holdings After Transaction: Common Stock — 52,636 shares (Direct, null)

Footnotes (1)

Key Figures

Shares purchased: 5,000 shares Purchase price: $11.19 per share Total holdings after transaction: 52,636 shares

3 metrics

Shares purchased 5,000 shares Open-market purchase on May 20, 2026

Purchase price $11.19 per share Price paid for Common Stock on May 20, 2026

Total holdings after transaction 52,636 shares Direct ownership of Common Stock following purchase

Key Terms

open-market purchase, Common Stock, non-derivative

3 terms

open-market purchase financial

"he purchased 5,000 shares of Common Stock at $11.19 per share in an open-market transaction"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Common Stock financial

"he purchased 5,000 shares of Common Stock at $11.19 per share"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

non-derivative financial

"The CEO purchased Crescent Capital BDC Common Stock as a non-derivative security"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Breaux Jason

(Last) (First) (Middle)

11100 SANTA MONICA BLVD

SUITE 2000

(Street)

LOS ANGELES CALIFORNIA 90025

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Crescent Capital BDC, Inc. [ CCAP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/20/2026	05/20/2026	P		5,000	A	$11.19	52,636	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ George P. Hawley, as Attorney-in-fact	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Crescent Capital BDC (CCAP) CEO Jason Breaux do in this Form 4?

Jason Breaux bought 5,000 shares of Crescent Capital BDC Common Stock in an open-market transaction. The purchase occurred at $11.19 per share, increasing his direct ownership to 52,636 shares.

How many Crescent Capital BDC (CCAP) shares did the CEO buy and at what price?

The CEO purchased 5,000 Crescent Capital BDC Common Stock shares at $11.19 per share. This was reported as an open-market purchase and reflects a direct ownership increase.

What is Jason Breaux’s total Crescent Capital BDC (CCAP) shareholding after the reported trade?

After the reported transaction, Jason Breaux directly holds 52,636 shares of Crescent Capital BDC Common Stock. This total includes the newly purchased 5,000 shares from the May 20, 2026 open-market trade.

Was the Crescent Capital BDC (CCAP) CEO’s Form 4 transaction a buy or a sell?

The Form 4 shows a buy transaction. Jason Breaux executed an open-market purchase of 5,000 Crescent Capital BDC Common Stock shares, with no sales reported in this filing.

What type of security did the Crescent Capital BDC (CCAP) CEO purchase?

The CEO purchased Crescent Capital BDC Common Stock as a non-derivative security. The Form 4 specifies an open-market purchase of 5,000 shares at a price of $11.19 per share.